首页> 外文期刊>Molecular Cancer >Orthotopic transplantation of retinoblastoma cells into vitreous cavity of zebrafish for screening of anticancer drugs
【24h】

Orthotopic transplantation of retinoblastoma cells into vitreous cavity of zebrafish for screening of anticancer drugs

机译:视网膜母细胞瘤细胞原位移植到斑马鱼玻璃体腔中以筛选抗癌药物

获取原文
           

摘要

Background With high throughput screening, novel therapeutic agents can be efficiently identified. Unfortunately, researchers only resort to in vitro cell viability assays for screening of anticancer drugs for retinoblastoma, the most common intraocular cancer in the childhood. Current available animal models of retinoblastoma require more than 2 weeks for tumour formation and the investigation of the efficacy of therapeutic agents. In this study, we established a novel orthotopic transplantation model of retinoblastoma in zebrafish as an in vivo animal model for screening of anticancer drugs. Methods We injected retinoblastoma cells into the vitreous cavity of zebrafish at 48 hours after fertilization. Eyeballs of zebrafish were scanned daily under the confocal laser microscope, and the tumor population was quantitatively analyzed by measuring the mean intensity of green fluorescent protein (GFP). Transplanted retinoblastoma cells were isolated to perform further analyses including Western blotting and reverse transcriptase-polymerase chain reaction to confirm that retinoblastoma cells maintained their characteristics as tumor cells even after transplantation and further isolation. To figure out the potential of this model for screening of anticancer drugs, zebrafish were cultured in Ringer ’s solution containing carboplatin and melphalan after the injection of retinoblastoma cells. Results The degree of the tumor population was dependent on the number of retinoblastoma cells injected and maintained stably for at least 4 days. Transplanted retinoblastoma cells maintain their proliferative potential and characteristics as retinoblastoma cells after isolation. Interestingly, systemic application of carboplatin and melphalan demonstrated significant reduction in the tumor population, which could be quantitatively analyzed by the estimation of the mean intensity of GFP. Conclusions This orthotopic retinoblastoma model in zebrafish is expected to be utilized for the screening of anticancer drugs for the treatment of retinoblastoma.
机译:背景技术通过高通量筛选,可以有效地鉴定新型治疗剂。不幸的是,研究人员仅求助于体外细胞生存力分析,以筛查视网膜母细胞瘤(儿童时期最常见的眼内癌)的抗癌药物。目前可用的视网膜母细胞瘤动物模型需要2个多星期的时间才能形成肿瘤并研究治疗剂的功效。在这项研究中,我们建立了一种新型的斑马鱼视网膜母细胞瘤原位移植模型,作为筛选抗癌药物的体内动物模型。方法我们在受精后48小时将视网膜母细胞瘤细胞注入斑马鱼的玻璃体腔中。每天在共聚焦激光显微镜下扫描斑马鱼的眼球,并通过测量绿色荧光蛋白(GFP)的平均强度对肿瘤种群进行定量分析。分离移植的成视网膜细胞瘤细胞以进行进一步的分析,包括蛋白质印迹和逆转录酶-聚合酶链反应,以确认成视网膜细胞瘤细胞即使在移植和进一步分离后仍保持其作为肿瘤细胞的特性。为了弄清这种模型筛选抗癌药物的潜力,在注射成视网膜细胞瘤细胞后,在含有卡铂和美法仑的林格氏溶液中培养斑马鱼。结果肿瘤种群的程度取决于注射的视网膜母细胞瘤细胞的数目,并能稳定维持至少4天。分离后,移植的视网膜母细胞瘤细胞保持其增殖潜力和特征。有趣的是,卡铂和美法仑的全身应用显示出肿瘤群体的显着减少,这可以通过估计GFP的平均强度来定量分析。结论斑马鱼原位视网膜母细胞瘤模型有望用于筛选治疗视网膜母细胞瘤的抗癌药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号